Events

View All

    World ADC London 2025: 7E2, a First-in-Class Anti-Human ALPP/ALPG Therapeutic ADC That Inhibits Tumor Growth in Human Pancreatic Cancer and Gastric Cancer PDX Models

    November 21, 2025
    Share on:
    The audio is muted. Click to unmute.